Havas Health Network has launched Havas Life London, an evolution of Havas Life Medicom that is “deeply rooted” in the agency’s leadership and specialised offerings.
The latest addition to the Havas Life group will be focused on connecting brand marketing and medical communications alongside a dedicated partnership with Havas Red’s life sciences public relations (PR) team.
The offering will be led by Sarah Mikhailov, managing director, rare; Dick Dunford, group creative director; Susan Walkley, managing director, PR and comms; and Gaynor Hayburn, group managing director. They hold extensive experience within the healthcare, creative and communications industries, and will be supported by a team of specialists in brand strategy, creative content, digital and social, and influencer engagement.
With cross-functional project teams across the agency, Havas Life London will offer brand, corporate and cause-related communications in global health and rare diseases. It also boasts a redefined structure and investment in creative impact, customer experience, merged media, as well as capabilities in technology and artificial intelligence (AI).
Mikhailov said: “Radical authenticity in rare product launches and disease awareness is non-negotiable. By striving to truly understand the unique experiences of people living with rare conditions, our mission is to craft relevant programmes that meaningfully support rare communities.”
Dunford added: “We want Havas Life London to illuminate the Havas Life network as a beacon of collaboration and creativity… Our focus on insightful strategies that drive powerful ideas will deliver measurable outcomes and ensure meaningful impact.”
The launch comes almost exactly one year after Havas Health & You (HH&Y) announced the expansion of Havas Lynx into North America.
Havas Lynx New York aims to create “authentic and meaningful experiences to engage with patients and improve outcomes at every step of the patient journey,” HH&Y said in the February 2024 statement.